Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 11 de 11
Filter
1.
J Investig Allergol Clin Immunol ; 32(6): 460-470, 2022 Dec 15.
Article in English | MEDLINE | ID: mdl-34489219

ABSTRACT

BACKGROUND AND OBJECTIVES: Shellfish allergy is a major cause of food allergy and anaphylaxis worldwide. Several allergenic proteins have been described in the last few years, but the only diagnostic tool that still enables discrimination between allergic and nonallergic sensitized persons is the oral food challenge (OFC). The aim of this study was to evaluate the usefulness of the nasal allergen provocation test (NAPT) as a diagnostic tool in shellfish allergy. METHODS: Forty-five patients with confirmed sensitization to shrimp by a positive skin prick test (SPT) result with a commercial shrimp extract were recruited and classified as sensitized-allergic or sensitized-nonallergic based on current tolerance to shrimp intake, the result of an OFC with a freeze-dried cooked shrimp mixture extract, or a recent history of anaphylaxis induced by shrimp ingestion. These patients and 10 controls not sensitized to shrimp underwent NAPT with a freeze-dried cooked shrimp mixture extract. The response was evaluated using acoustic rhinometry and a visual analog scale. RESULTS: Significant differences (P=.001) were found between the sensitized-allergic group (18/20 positive NAPT, 90%) and both the sensitized-nonallergic group (2/18 positive NAPT, 11.1%) and controls (0/10 positive NAPT). NAPT enables differentiation between allergic and nonallergic persons with a sensitivity of 90%, specificity of 89%, positive predictive value of 90%, and negative predictive value of 89%. CONCLUSIONS: Our results indicate that NAPT makes it possible to differentiate between sensitized symptomatic patients and sensitized tolerant patients and could be a valuable diagnostic tool when assessing shrimp allergy.


Subject(s)
Anaphylaxis , Shellfish Hypersensitivity , Humans , Allergens , Shellfish Hypersensitivity/diagnosis , Immunoglobulin E , Nasal Provocation Tests , Skin Tests , Plant Extracts
2.
J Investig Allergol Clin Immunol ; 32(4): 282-290, 2022 Jul 22.
Article in English | MEDLINE | ID: mdl-33944786

ABSTRACT

BACKGROUND AND OBJECTIVE: The prevalence of anaphylactic shock, the most severe manifestation of anaphylaxis, remains unknown. Risk factors and biomarkers have not been fully identified. Objective: To identify risk factors in patients who experience anaphylactic shock. METHODS: Using lipid transfer protein (LTP) allergy as a model, we compared the characteristics of patients who developed anaphylaxis and anaphylactic shock. We recorded demographics, pollen sensitization, foods ingested up to 2 hours before onset of the reaction, and the presence of cofactors. Culprit foods were identified through a compatible clinical history and positive allergology work-up (skin prick test and/or sIgE). RESULTS: We evaluated 150 reactions in 55 patients with anaphylaxis (134 reactions) and 12 with anaphylactic shock (16 reactions). Patients in the anaphylaxis group experienced twice as many reactions (mean [SD], 2.4 [2.5] for anaphylaxis vs 1.3 [1.5] for anaphylactic shock; P<.02). No relationship was found between any food group and severity of the reaction. The most frequent food involved in both groups of patients was the combination of several plant-derived foods (plant food mix), followed by peach and nuts. Indeed, in the reactions caused by plant food mix, the presence of a cofactor was observed more often than in other food groups. On the other hand, cofactors were not present in peach- and nut-related reactions. Exercise was the most frequent cofactor in all groups. CONCLUSION: In our series, the severity of the reactions was not determined by the kind of food or presence of a cofactor. Anaphylactic shock seems to be an infrequent presentation that may be associated with other individual-related factors requiring further evaluation.


Subject(s)
Anaphylaxis , Food Hypersensitivity , Prunus persica , Allergens , Anaphylaxis/diagnosis , Anaphylaxis/epidemiology , Anaphylaxis/etiology , Antigens, Plant , Food Hypersensitivity/diagnosis , Food Hypersensitivity/epidemiology , Humans , Nuts , Plant Proteins , Prunus persica/adverse effects , Risk Factors
3.
J. investig. allergol. clin. immunol ; 32(4): 282-290, 2022. tab
Article in English | IBECS | ID: ibc-208240

ABSTRACT

Background: The prevalence of anaphylactic shock, the most severe manifestation of anaphylaxis, remains unknown. Risk factors and biomarkers have not been fully identified. Objective: To identify risk factors in patients who experience anaphylactic shock. Methods: Using lipid transfer protein (LTP) allergy as a model, we compared the characteristics of patients who developed anaphylaxis and anaphylactic shock. We recorded demographics, pollen sensitization, foods ingested up to 2 hours before onset of the reaction, and the presence of cofactors. Culprit foods were identified through a compatible clinical history and positive allergology work-up (skin prick test and/or sIgE). Results: We evaluated 150 reactions in 55 patients with anaphylaxis (134 reactions) and 12 with anaphylactic shock (16 reactions). Patients in the anaphylaxis group experienced twice as many reactions (mean [SD], 2.4 [2.5] for anaphylaxis vs 1.3 [1.5] for anaphylactic shock; P<.02). No relationship was found between any food group and severity of the reaction. The most frequent food involved in both groups of patients was the combination of several plant-derived foods (plant food mix), followed by peach and nuts. Indeed, in the reactions caused by plant food mix, the presence of a cofactor was observed more often than in other food groups. On the other hand, cofactors were not present in peach- and nut-related reactions. Exercise was the most frequent cofactor in all groups. Conclusion: In our series, the severity of the reactions was not determined by the kind of food or presence of a cofactor. Anaphylactic shock seems to be an infrequent presentation that may be associated with other individual-related factors requiring further evaluation (AU)


Antecedentes: La prevalencia del shock anafiláctico sigue siendo desconocida. Aún no se han identificado completamente factores de riesgo ni biomarcadores. Objetivo: Identificar factores de riesgo de shock anafiláctico. Método: Utilizando la alergia a proteína de transferencia de lípidos (LTP) como modelo, se han comparado características de pacientes que han presentado una anafilaxia (An) y pacientes que han desarrollado un shock anafiláctico (SAn). Se recopilaron datos demográficos, sensibilización a pólenes, alimentos ingeridos hasta 2 horas antes del inicio de la reacción y la presencia o no de cofactores. El alimento implicado se identificó mediante historia clínica compatible y estudio alergológico positivo (prick test y/o IgE). Resultados: Se evaluaron un total de 150 reacciones; 55 pacientes del grupo An sufrieron 134 reacciones, y 12 pacientes del grupo SAn sufrieron 16 reacciones. El grupo An experimentó el doble de reacciones por paciente (media [DS] 2,4 [2,5] en An vs 1,3 [1,5] en SAn, p<0,02). No se observó relación entre el tipo de alimento y la gravedad de la reacción. El alimento implicado con más frecuencia en ambos grupos fue la combinación de varios vegetales (“mix de vegetales”), seguido por el melocotón y frutos secos. No hubo cofactores implicados en las reacciones con melocotón ni con frutos secos. En ambos grupos el eje rcicio fue el cofactor involucrado con más frecuencia.Conclusión: En nuestra serie, el alimento y la presencia de cofactor no determinan la gravedad de una reacción. Los shocks anafilácticos parecen ser una presentación infrecuente y podrían estar relacionados con factores individuales que precisarán una evaluación más extensa (AU)


Subject(s)
Humans , Male , Female , Adult , Middle Aged , Allergens/adverse effects , Anaphylaxis/etiology , Food Hypersensitivity/diagnosis , Food Hypersensitivity/epidemiology , Prunus persica/adverse effects , Anaphylaxis/diagnosis , Antigens, Plant/immunology , Risk Factors
4.
J. investig. allergol. clin. immunol ; 32(6): 460-470, 2022. ilus, tab, graf
Article in English | IBECS | ID: ibc-213397

ABSTRACT

Background: Shellfish allergy is a major cause of food allergy and anaphylaxis worldwide. Several allergenic proteins have been described in the last few years, but the only diagnostic tool that still enables discrimination between allergic and nonallergic sensitized persons is the oral food challenge (OFC). Objective: The aim of this study was to evaluate the usefulness of the nasal allergen provocation test (NAPT) as a diagnostic tool in shellfish allergy. Methods: Forty-five patients with confirmed sensitization to shrimp by a positive skin prick test (SPT) result with a commercial shrimp extract were recruited and classified as sensitized-allergic or sensitized-nonallergic based on current tolerance to shrimp intake, the result of an OFC with a freeze-dried cooked shrimp mixture extract, or a recent history of anaphylaxis induced by shrimp ingestion. These patients and 10 controls not sensitized to shrimp underwent NAPT with a freeze-dried cooked shrimp mixture extract. The response was evaluated using acoustic rhinometry and a visual analog scale. Results: Significant differences (P=.001) were found between the sensitized-allergic group (18/20 positive NAPT, 90%) and both the sensitized-nonallergic group (2/18 positive NAPT, 11.1%) and controls (0/10 positive NAPT). NAPT enables differentiation between allergic and nonallergic persons with a sensitivity of 90%, specificity of 89%, positive predictive value of 90%, and negative predictive value of 89%. Conclusions: Our results indicate that NAPT makes it possible to differentiate between sensitized symptomatic patients and sensitized tolerant patients and could be a valuable diagnostic tool when assessing shrimp allergy (AU)


Subject(s)
Humans , Male , Female , Young Adult , Adult , Shellfish Hypersensitivity/diagnosis , Nasal Provocation Tests/methods , Prospective Studies , Rhinometry, Acoustic , Skin Tests
5.
J Investig Allergol Clin Immunol ; 31(5): 385-403, 2021 Oct 25.
Article in English | MEDLINE | ID: mdl-33653682

ABSTRACT

The controlled drug provocation test (DPT) is currently considered the gold standard for the diagnosis of drug allergy. Adverse drug reactions (ADRs) are an increasingly common presenting complaint in both primary and specialized care. In Spain, ADRs are usually assessed via the allergology department, which rules out immunological mechanisms in up to 90% of cases. An adequate approach to ADRs clearly impacts the costs and efficacy of the treatments prescribed by other specialists. Consequently, if we did not use DPTs, patients would require more expensive, more toxic, and less effective treatments in many cases. In recent years, many new drugs have been developed. This document is intended to be a practical guideline for the management of DPTs according to the vision of the Spanish Allergology Society. The diagnostic work-up begins with a detailed clinical history. Skin tests are only useful for some medications, and in most cases the diagnosis can only be confirmed by DPT. Although cross-reactivity is common, DPTs can confirm the diagnosis and help to find an alternative drug. Programmed individualized patient management based on the type of drug to be studied and the patient´s comorbidities usually enables a solution to be found in most cases.


Subject(s)
Drug Hypersensitivity , Drug-Related Side Effects and Adverse Reactions , Pharmaceutical Preparations , Drug Hypersensitivity/diagnosis , Humans , Skin Tests , Spain
6.
J. investig. allergol. clin. immunol ; 31(5): 385-403, 2021. tab, ilus
Article in English | IBECS | ID: ibc-216382

ABSTRACT

The controlled drug provocation test (DPT) is currently considered the gold standard for the diagnosis of drug allergy. Adverse drug reactions (ADRs) are an increasingly common presenting complaint in both primary and specialized care. In Spain, ADRs are usually assessed via the allergology department, which rules out immunological mechanisms in up to 90% of cases. An adequate approach to ADRs clearly impacts the costs and efficacy of the treatments prescribed by other specialists. Consequently, if we did not use DPTs, patients would require more expensive, more toxic, and less effective treatments in many cases. In recent years, many new drugs have been developed. This document is intended to be a practical guideline for the management of DPTs according to the vision of the Spanish Allergology Society. The diagnostic work-up begins with a detailed clinical history. Skin tests are only useful for some medications, and in most cases the diagnosis can only be confirmed by DPT. Although cross-reactivity is common, DPTs can confirm the diagnosis and help to find an alternative drug. Programmed individualized patient management based on the type of drug to be studied and the patient's comorbidities usually enables a solution to be found in most cases (AU)


La prueba de exposición controlada a fármacos (DPT) se considera actualmente el estándar de oro para el diagnóstico de alergia amedicamentos. Las reacciones adversas inducidas por medicamentos (RAM) son un motivo creciente de consulta tanto en atención primariacomo especializada. Las consultas de Alergología en España son las que habitualmente estudian estas RAM y descartan mecanismosinmunológicos implicados hasta en el 90% de los casos consultados. Un abordaje adecuado de estos casos repercute de una maneraevidente en los costes y la eficacia de los tratamientos requeridos por otros especialistas, de modo que, si no empleáramos los DPT, lospacientes requerirían tratamientos más costosos, más tóxicos y menos eficaces en la mayoría de los casos.En los últimos años se han desarrollado un gran número de nuevos fármacos y este documento pretende ser una guía práctica en lagestión de las DPT con la visión de la Sociedad Española de Alergología. El trabajo de diagnóstico comienza con un historial detalladodel paciente. Las pruebas cutáneas solo son útiles en algunos medicamentos y, en la mayoría de los casos, el diagnóstico solo puedeconfirmarse mediante el DPT. Aunque suele haber reactividad cruzada, las DPT pueden confirmar el diagnóstico y también contribuir aencontrar un fármaco alternativo tolerable. El manejo individual de los pacientes de forma programada, teniendo en cuenta tanto eltipo de fármaco a estudiar como las comorbilidades del paciente, suele permitir encontrar una solución para la mayoría de los pacientes (AU)


Subject(s)
Humans , Drug Hypersensitivity/diagnosis , Drug-Related Side Effects and Adverse Reactions , Pharmaceutical Preparations , Societies, Medical , Skin Tests , Spain
7.
J Investig Allergol Clin Immunol ; 30(6): 409-420, 2020.
Article in English | MEDLINE | ID: mdl-32694101

ABSTRACT

Seafood is a major cause of food allergy and anaphylaxis worldwide. Shellfish is included among the "big eight" food groups, which are responsible for more than 90% of all cases of food allergy. Approximately 2.5% of the world's population has experienced an adverse reaction to seafood. Seafood allergy is one of the most frequent and lethal allergies that exist. The several allergenic proteins involved in allergic reactions that have been described in recent years include tropomyosin, arginine kinase, myosin light chain, and sarcoplasmic calcium-binding protein. Despite all the data reported in the last few years, shellfish allergy is still diagnosed and treated as it was 50 years ago. The only effective treatment to prevent allergic reactions to shellfish is avoidance. This review aims to update recently published data on shellfish allergy and to highlight those areas that have yet to be resolved.


Subject(s)
Shellfish Hypersensitivity/diagnosis , Shellfish Hypersensitivity/therapy , Algorithms , Allergens/immunology , Animals , Clinical Decision-Making , Cross Reactions/immunology , Disease Management , Disease Susceptibility , Epitopes/immunology , Humans , Immunoglobulin E/immunology , Risk Factors , Shellfish/adverse effects , Shellfish Hypersensitivity/etiology , Symptom Assessment
8.
J. investig. allergol. clin. immunol ; 30(6): 409-420, 2020. tab, graf
Article in English | IBECS | ID: ibc-202593

ABSTRACT

Seafood is a major cause of food allergy and anaphylaxis worldwide. Shellfish is included among the "big eight" food groups, which are responsible for more than 90% of all cases of food allergy. Approximately 2.5% of the world's population has experienced an adverse reaction to seafood. Seafood allergy is one of the most frequent and lethal allergies that exist. The several allergenic proteins involved in allergic reactions that have been described in recent years include tropomyosin, arginine kinase, myosin light chain, and sarcoplasmic calcium-binding protein. Despite all the data reported in the last few years, shellfish allergy is still diagnosed and treated as it was 50 years ago. The only effective treatment to prevent allergic reactions to shellfish is avoidance. This review aims to update recently published data on shellfish allergy and to highlight those areas that have yet to be resolved


La alergia al marisco es una causa importante de alergia alimentaria y anafilaxia en todo el mundo. Los mariscos se incluyen entre los "ocho grandes" grupos de alimentos, responsables de más del 90% de todos los casos de alergia alimentaria. Aproximadamente el 2,5% de la población mundial ha experimentado alguna reacción adversa a los mariscos. La alergia al marisco es una de las alergias más frecuentes y letales que existen. Se han descrito varias proteínas alergénicas involucradas en las reacciones alérgicas en los últimos años: tropomiosina, arginina quinasa, cadena ligera de la miosina, proteína de unión a calcio, entre otras. A pesar de la información obtenida en los últimos años, la alergia a los mariscos todavía se diagnostica y trata como hace 50 años. Actualmente, el único tratamiento efectivo para prevenir reacciones alérgicas a los mariscos es la evitación. Esta revisión tiene como objetivo recoger todas las actualizaciones realizadas en las publicaciones de los últimos años y resaltar las cuestiones pendientes de resolver


Subject(s)
Humans , Shellfish Hypersensitivity , Fish Products/adverse effects , Anaphylaxis/etiology , Shellfish/analysis
9.
Aust Vet J ; 89(1-2): 47-50, 2011 Jan.
Article in English | MEDLINE | ID: mdl-21250956

ABSTRACT

The neurological, clinical and pathological findings and endoparasites in 10 wild tawny frogmouths (Podargus strigoides) presented to the Australian Wildlife Hospital in Beerwah, Queensland during a 28-day period in May 2009 are reported. Affected birds had a history of being found in poor body condition on the ground and unable to fly. Clinical examination revealed paresis with variable but generally weakened deep pain responses, withdrawal reflexes and an inability to perch. Severely affected birds that failed to respond to anti-inflammatory, antibiotic and anthelmintic treatments all had larval Angiostrongylus cantonensis in the brain and or spinal cord, with occasional larvae found in the visceral organs. Other parasites detected included the liver fluke, Brachylecithum podargi, the intestinal nematode, Allodapa suctoria, an unidentified species of Trichostrongylus and unidentified cestodes. Gametocytes of Leucocytozoon sp. were found in peripheral blood smears and low numbers of microfilariae were found in histological sections of various blood vessels of several birds. However, no adult filarioids were recovered. Unidentified subcutaneous mites were identified in the connective tissue of the thoracic inlet. Attempts to treat two birds with ivermectin or oxfendazole-praziquantel were unsuccessful, but a third bird treated with a combination of steroidal and non-steroidal anti-inflammatory therapy followed by moxidectin steadily recovered, such that by 6 weeks post presentation its ability to perch, grasp, fly and judge distances was considered normal and it was subsequently released.


Subject(s)
Animals, Wild/parasitology , Bird Diseases/epidemiology , Strongylida Infections/veterinary , Angiostrongylus/isolation & purification , Animals , Birds , Queensland/epidemiology , Strongylida Infections/epidemiology
10.
Aust Vet J ; 78(3): 182-3, 2000 Mar.
Article in English | MEDLINE | ID: mdl-10860158

ABSTRACT

OBJECTIVE: To perform a morphological and genetic characterisation of a Cryptosporidium infection in an Indian ring-necked parrot (Psittacula krameri) and to compare this with C meleagridis from a turkey. DESIGN: Tissue and intestinal sections from an Indian ring-necked parrot were examined microscopically for Cryptosporidium. The organism was also purified from the crop and intestine, the DNA extracted and a portion of the 18S rDNA gene amplified, sequenced and compared with sequence and biological information obtained for C meleagridis from a turkey as well as sequence information for other species of Cryptosporidium. RESULTS: Morphological examination of tissue sections from an Indian ring-necked parrot revealed large numbers of Cryptosporidium oocysts attached to the apical border of enterocytes lining the intestinal tract. Purified Cryptosporidium oocysts measured about 5.1 x 4.5 microns, which conformed morphologically to C meleagridis. The sequence obtained from this isolate was identical to sequence information obtained from a C meleagridis isolate from a turkey. CONCLUSION: Cryptosporidium meleagridis was detected in an Indian ring-necked parrot using morphological and molecular methods. This is the first time that this species of Cryptosporidium has been reported in a non-galliform host and extends the known host range of C meleagridis.


Subject(s)
Bird Diseases/parasitology , Cryptosporidiosis/veterinary , Cryptosporidium/isolation & purification , Parrots/parasitology , Poultry Diseases/parasitology , Turkeys/parasitology , Animals , Bird Diseases/pathology , Cryptosporidiosis/parasitology , Cryptosporidiosis/pathology , Cryptosporidium/genetics , DNA, Protozoan/isolation & purification , Polymerase Chain Reaction/veterinary , Poultry Diseases/pathology , RNA, Ribosomal, 18S/genetics
SELECTION OF CITATIONS
SEARCH DETAIL
...